| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kinnate Biopharma Inc (NASDAQ: KNTE)
KNTE Technical Analysis
5
| As on 9th Jun 2023 KNTE STOCK Price closed @ 3.41 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.17 & Strong Sell for SHORT-TERM with Stoploss of 12.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KNTESTOCK Price
| Open | 3.73 | Change | Price | % |
| High | 3.73 | 1 Day | -0.32 | -8.58 |
| Low | 3.37 | 1 Week | -0.32 | -8.58 |
| Close | 3.41 | 1 Month | 0.79 | 30.15 |
| Volume | 315187 | 1 Year | -13.71 | -80.08 |
| 52 Week High 18.40 | 52 Week Low 2.33 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KNTE Daily Charts |
KNTE Intraday Charts |
Whats New @ Bazaartrend |
KNTE Free Analysis |
|
|
KNTE Important Levels Intraday
| RESISTANCE | 4.10 |
| RESISTANCE | 3.88 |
| RESISTANCE | 3.74 |
| RESISTANCE | 3.61 |
| SUPPORT | 3.21 |
| SUPPORT | 3.08 |
| SUPPORT | 2.94 |
| SUPPORT | 2.72 |
KNTE Forecast April 2024
| 4th UP Forecast | 18.46 |
| 3rd UP Forecast | 13.63 |
| 2nd UP Forecast | 10.65 |
| 1st UP Forecast | 7.67 |
| 1st DOWN Forecast | -0.85 |
| 2nd DOWN Forecast | -3.83 |
| 3rd DOWN Forecast | -6.81 |
| 4th DOWN Forecast | -11.64 |
KNTE Weekly Forecast
| 4th UP Forecast | 9.40 |
| 3rd UP Forecast | 7.48 |
| 2nd UP Forecast | 6.29 |
| 1st UP Forecast | 5.10 |
| 1st DOWN Forecast | 1.72 |
| 2nd DOWN Forecast | 0.53 |
| 3rd DOWN Forecast | -0.66 |
| 4th DOWN Forecast | -2.58 |
KNTE Forecast2024
| 4th UP Forecast | 35.8 |
| 3rd UP Forecast | 25.41 |
| 2nd UP Forecast | 18.99 |
| 1st UP Forecast | 12.57 |
| 1st DOWN Forecast | -5.75 |
| 2nd DOWN Forecast | -12.17 |
| 3rd DOWN Forecast | -18.59 |
| 4th DOWN Forecast | -28.98 |
Kinnate Biopharma Inc ( NASDAQ USA Symbol : KNTE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KNTE Business Profile
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers. It develops KIN-2787, which is a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors (FGFR)2 and FGFR3 genes; and small molecule research programs, including a Cyclin-Dependent Kinase 12 inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Diego, California. Address: 11975 El Camino Real, San Diego, CA, United States, 92130
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service